Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity (EXEC)
Mild Cognitive Impairment, Chronic Kidney Diseases
About this trial
This is an interventional other trial for Mild Cognitive Impairment focused on measuring mild cognitive impairment, chronic kidney disease, exercise, Lifestyle behavior, home-based exercise
Eligibility Criteria
Inclusion Criteria: • Diagnosed stage 3-4 chronic kidney disease (CKD, estimated glomerular filtration rate (eGFR) <60 to 20 ml/min); >55 yrs of age Mild cognitive impairment (18-26 on the MOCA) ability to undergo an MR no history of major head trauma (No head trauma/concussion with loss of consciousness) Speaks, reads, writes English Exclusion Criteria: • Diagnosed Dementia or a Clinical Dementia Rating Scale score of <2, or a MOCA of <18 Participating in a supervised exercise program with intent to increase fitness levels 3 days/week, Requires assistive ambulation Limited exercise capacity due to claudication; unstable angina, severe arthritis, extreme dyspnea on exertion, unstable coronary artery disease Class III-IV heart failure History of uncontrolled sustained arrhythmias, severe/symptomatic aortic or mitral stenosis, hypertrophic obstructive cardiomyopathy, severe pulmonary hypertension, active myocarditis/pericarditis, thrombophlebitis, and recent systemic/pulmonary embolus Resting systolic BP >200 mmHg or resting diastolic BP >110 mmHg Any unforeseen illness or disability that would preclude cognitive testing or exercise training One or more contraindication for MRI; cardiac pacemaker, aneurysm clip, cochlear implants, shrapnel, history of metal fragments in eyes, neurostimulators, diagnosed claustrophobia (MRI only) Any self-reported major psychiatric disorders requiring medical therapy (e.g. schizophrenia, bipolar disorder). Self-reported new diagnosis of clinical depression within 3 months of enrollment or unstable clinical depression requiring medication adjustment within 3 months of enrollment
Sites / Locations
- Columbia University
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Home-based walking exercise
Health education
A 6-month partially supervised walking exercise training using a tapered approach. Participants begin with exercising (walking) in person, on-site one time per week and 3 times per week at home for a minimum exercise dosage of 30 minutes of accumulated exercise per session during month 1. During month 2, participants will exercise on-site once every other week and 3-4 times per week at home a minimum exercise dosage of 30 minutes of accumulated exercise per session. During months 2-6, participants will exercise at home 4 times per week for a minimum exercise dosage of 30 minutes of accumulated exercise per session and they will receive a phone call every two weeks to help coach and address any problems. Participants will receive a Fitbit fitness tracker that will be used to deliver their personalized exercise program, exercise monitoring, feedback, and motivational messages.
The health education group will receive the same amount of contact hours as the intervention group. The attention control group will receive health education and stretching exercises. Participants will be in person, on-site one time per week during month 1 for about 30 minutes. During month 2, participants will attend the health education on-site once every other week for about 30 minutes. During months 2-6 participants will receive a phone call every two weeks to help remind about the health education. Participants will receive a Fitbit fitness tracker that will be used for exercise monitoring.